The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Using single-cell transcriptomics to reveal CD226 upregulation and enhancement of CD19-CAR-T function in the inhibitory CNS microenvironment of refractory CNS lymphoma.
 
Ulrike Gerdemann
Employment - Merus (I)
Leadership - Merus (I)
Stock and Other Ownership Interests - Alovir; Immunogen (I); Merus (I); Merus (I); Pfizer (I)
Research Funding - Kite, a Gilead company; Tessera
Patents, Royalties, Other Intellectual Property - pending patent for Ox40 Car TREGs PCT/US2023/014032; Royalties in Alovir
 
James Kaminski
No Relationships to Disclose
 
Alexandre Albanese
No Relationships to Disclose
 
Isabella Schichter
No Relationships to Disclose
 
Paula Keskula
No Relationships to Disclose
 
Ryan Fleming
No Relationships to Disclose
 
Fran Alvarez-Calderon
Stock and Other Ownership Interests - Editas medicine, inc
 
Lorenzo Cagnin
No Relationships to Disclose
 
Jillian Zavistaski
No Relationships to Disclose
 
Austin Moore
No Relationships to Disclose
 
Soumya Poddar
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
Patents, Royalties, Other Intellectual Property - UC LA
 
Ugonma Chukwueke
Stock and Other Ownership Interests - Abbott Laboratories (I); Abbvie (I); Becton Dickinson (I); Danaher (I); Johnson and Johnson (I); Medtronic (I); Novartis (I)
 
Lea Steinberg
Employment - Regata Therapeutics
 
Michael Mattie
Employment - Kite, a Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
Patents, Royalties, Other Intellectual Property - Gilead Sciences
 
Caroline Falvey
No Relationships to Disclose
 
Riemke Bouvier
No Relationships to Disclose
 
Alexandra Torres
No Relationships to Disclose
 
Caron Jacobson
Honoraria - Abbvie; ADC Therapeutics; Aleta Biotherapeutics; Appia Bio; AstraZeneca; Bristol-Myers Squibb; Caribou Biosciences; Janssen; Kite/Gilead; Kyverna Therapeutics; Miltenyi Biomedicine; Novartis; Sana; Synthekine
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Aleta Biotherapeutics; Appia Bio; AstraZeneca; Bristol-Myers Squibb; Janssen; Kite/Gilead; Kyverna Therapeutics; Miltenyi Biomedicine; Novartis; Sana; Synthekine
Research Funding - Kite, a Gilead company
 
Lakshmi Nayak
Honoraria - Ono Pharmaceutical
Consulting or Advisory Role - BraveBio; Genmab; Kite/Gilead; Ono Pharmaceutical
Speakers' Bureau - Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Kazia Therapeutics (Inst); Merck (Inst); Ono Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - Wolters Kluwer/ UpToDate, Inc- Royalty
Travel, Accommodations, Expenses - Ono Pharmaceutical
 
Leslie Kean
Consulting or Advisory Role - HiFiBiO Therapeutics; Vertex
Research Funding - Bristol Myers Squibb; Regeneron; Tessera; Tonix
Patents, Royalties, Other Intellectual Property - Licensing Fees for ABA2 clinical trial data.